ETF Managers Group’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

ETF Managers Group’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,107	Closed	-$26K	–	851
2022 Q2	$26K	Buy	7,107 +323	+5%	+$1.13K	﹤0.01%	732
2022 Q1	$43K	Buy	6,784 +23	+0.3%	+$144	﹤0.01%	665
2021 Q4	$74K	Sell	6,761 -1,007	-13%	-$14K	﹤0.01%	651
2021 Q3	$125K	Buy	7,768 +1,265	+19%	+$22.6K	﹤0.01%	633
2021 Q2	$123K	Sell	6,503 -100	-2%	-$1.92K	﹤0.01%	618
2021 Q1	$92K	Sell	6,603 -2,525	-28%	-$54.9K	﹤0.01%	641
2020 Q4	$256K	Buy	+9,128	New	+$121K	0.01%	566

Other funds holding CDAK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ETF Managers Group's CDAK Position: Q3 2022 in Review

ETF Managers Group sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q3 2022, closing a stake of 7,107 shares — an estimated $26K sold.

ETF Managers Group first reported a position in CDAK in Q4 2020 and held it in 7 quarters. The position peaked at $256K in Q4 2020. 48 funds tracked by Wall St. Rank hold CDAK as of Q3 2022.

ETF Managers Group reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
ETF Managers Group sold 7,107 Codiak BioSciences, Inc. Common Stock shares in Q3 2022, an estimated $26K.
ETF Managers Group first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
ETF Managers Group's Codiak BioSciences, Inc. Common Stock position peaked at $256K in Q4 2020.
48 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q3 2022.

Based on ETF Managers Group's 13F filing for Q3 2022, filed 14 Nov 2022.